These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 23946173)

  • 1. Diagnostic strategies for invasive fungal infections in patients with hematologic malignancies and hematopoietic stem cell transplant recipients.
    Norkin M; Wingard JR
    J Natl Compr Canc Netw; 2013 Aug; 11(8):941-9. PubMed ID: 23946173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Detection of 1,3-beta-D glucan for diagnosis of invasive fungal infections in hematooncological patients: usefulness for screening of invasive mycosis and for confirmation of galactomannan positive results].
    Rácil Z; Kocmanová I; Weinbergerová B; Winterová J; Lengerová M; Hrncírová K; Mayer J
    Klin Mikrobiol Infekc Lek; 2009 Apr; 15(2):48-57. PubMed ID: 19488961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of biomarkers: Galactomannan and 1,3-beta-D-glucan assay for the diagnosis of invasive fungal infections in immunocompromised patients from a tertiary care centre.
    Singh S; Kaur H; Choudhary H; Sethi S; Malhotra P; Gupta KL; Rudramurthy SM; Chakrabarti A
    Indian J Med Microbiol; 2018; 36(4):557-563. PubMed ID: 30880706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Approaches to the management of invasive fungal infections in hematologic malignancy and hematopoietic cell transplantation.
    Michallet M; Ito JI
    J Clin Oncol; 2009 Jul; 27(20):3398-409. PubMed ID: 19487382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic methodologies for invasive fungal infections in hematopoietic stem-cell transplant recipients.
    Somboonwit C; Greene JN
    Semin Respir Infect; 2002 Jun; 17(2):151-7. PubMed ID: 12070834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of micafungin as an empirical therapy for invasive fungal infections in patients with hematologic disorders: a multicenter, prospective study.
    Yamaguchi M; Kurokawa T; Ishiyama K; Aoki G; Ueda M; Matano S; Takami A; Yamazaki H; Sawazaki A; Yamauchi H; Yoshida T; Nakao S
    Ann Hematol; 2011 Oct; 90(10):1209-17. PubMed ID: 21695388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. β-Glucan antigenemia assay for the diagnosis of invasive fungal infections in patients with hematological malignancies: a systematic review and meta-analysis of cohort studies from the Third European Conference on Infections in Leukemia (ECIL-3).
    Lamoth F; Cruciani M; Mengoli C; Castagnola E; Lortholary O; Richardson M; Marchetti O;
    Clin Infect Dis; 2012 Mar; 54(5):633-43. PubMed ID: 22198786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Have novel serum markers supplanted tissue diagnosis for invasive fungal infections in acute leukemia and transplantation?
    Wingard JR
    Best Pract Res Clin Haematol; 2012 Dec; 25(4):487-91. PubMed ID: 23200547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. (1, 3)-β-D-glucan assay for diagnosing invasive fungal infections in critically ill patients with hematological malignancies.
    Azoulay E; Guigue N; Darmon M; Mokart D; Lemiale V; Kouatchet A; Mayaux J; Vincent F; Nyunga M; Bruneel F; Rabbat A; Bretagne S; Lebert C; Meert AP; Benoit D; Pene F
    Oncotarget; 2016 Apr; 7(16):21484-95. PubMed ID: 26910891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fungal Pneumonia in Patients with Hematologic Malignancy and Hematopoietic Stem Cell Transplantation.
    Young AY; Leiva Juarez MM; Evans SE
    Clin Chest Med; 2017 Sep; 38(3):479-491. PubMed ID: 28797490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risks, diagnosis and outcomes of invasive fungal infections in haematopoietic stem cell transplant recipients.
    Barnes PD; Marr KA
    Br J Haematol; 2007 Nov; 139(4):519-31. PubMed ID: 17979942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fungal Infections of the Stem Cell Transplant Recipient and Hematologic Malignancy Patients.
    Bays DJ; Thompson GR
    Infect Dis Clin North Am; 2019 Jun; 33(2):545-566. PubMed ID: 31005138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention and early treatment of invasive fungal infection in patients with cancer and neutropenia and in stem cell transplant recipients in the era of newer broad-spectrum antifungal agents and diagnostic adjuncts.
    Segal BH; Almyroudis NG; Battiwalla M; Herbrecht R; Perfect JR; Walsh TJ; Wingard JR
    Clin Infect Dis; 2007 Feb; 44(3):402-9. PubMed ID: 17205448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retrospective assessment of β-D-(1,3)-glucan for presumptive diagnosis of fungal infections.
    Bellanger AP; Grenouillet F; Henon T; Skana F; Legrand F; Deconinck E; Millon L
    APMIS; 2011 Apr; 119(4-5):280-6. PubMed ID: 21492228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging fungal pathogens in patients with hematologic malignancies and marrow/stem-cell transplant recipients.
    Jahagirdar BN; Morrison VA
    Semin Respir Infect; 2002 Jun; 17(2):113-20. PubMed ID: 12070830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database.
    Kontoyiannis DP; Marr KA; Park BJ; Alexander BD; Anaissie EJ; Walsh TJ; Ito J; Andes DR; Baddley JW; Brown JM; Brumble LM; Freifeld AG; Hadley S; Herwaldt LA; Kauffman CA; Knapp K; Lyon GM; Morrison VA; Papanicolaou G; Patterson TF; Perl TM; Schuster MG; Walker R; Wannemuehler KA; Wingard JR; Chiller TM; Pappas PG
    Clin Infect Dis; 2010 Apr; 50(8):1091-100. PubMed ID: 20218877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry.
    Neofytos D; Horn D; Anaissie E; Steinbach W; Olyaei A; Fishman J; Pfaller M; Chang C; Webster K; Marr K
    Clin Infect Dis; 2009 Feb; 48(3):265-73. PubMed ID: 19115967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Spectrum, Diagnosis and Outcome of Rare Fungal Infections in Patients with Hematological Malignancies: Experience of 15-Year Period from a Single Tertiary Medical Center.
    Hardak E; Fuchs E; Geffen Y; Zuckerman T; Oren I
    Mycopathologia; 2020 Apr; 185(2):347-355. PubMed ID: 32100219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Galactomannan testing in bronchoalveolar lavage fluid facilitates the diagnosis of invasive pulmonary aspergillosis in patients with hematologic malignancies and stem cell transplant recipients.
    Nguyen MH; Leather H; Clancy CJ; Cline C; Jantz MA; Kulkarni V; Wheat LJ; Wingard JR
    Biol Blood Marrow Transplant; 2011 Jul; 17(7):1043-50. PubMed ID: 21087680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Investigation of the cutoff value of a serum 1,3-beta-D-glucan assay for early diagnosis of invasive fungal infection in Chinese hematopoietic stem cell transplant recipients].
    Ji Y; Huang XJ
    Zhonghua Xue Ye Xue Za Zhi; 2008 Jun; 29(6):405-7. PubMed ID: 19031745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.